Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.940 EUR | -0.42% | -4.57% | -72.02% |
05/09 | Evotec, X-Chem to Collaborate on Early-Stage Drug Discovery | MT |
05/09 | Evotec SE and X-Chem Inc. Collaborates to Accelerate Early-Stage Drug Discovery | CI |
Analyst Opinion | 4m Target Price Revision | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Average Target P. | Ecart obj. / dr | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|---|
13.64 | +128.67% | 10 | |||||||
623.67 | +14.81% | 21 | |||||||
276.53 | +14.81% | 21 | |||||||
283.17 | +11.85% | 27 | |||||||
246,777.78 | +28.46% | 18 | |||||||
125.71 | +64.10% | 21 | |||||||
365.40 | +22.33% | 15 | |||||||
350.71 | +0.57% | 13 | |||||||
82.55 | +14.52% | 13 | |||||||
406.91 | +19.90% | 9 | |||||||
50.97 | +11.08% | 17 | |||||||
224.07 | +19.09% | 17 | |||||||
- | 46.00 | -2.69% | 8 | ||||||
62.91 | +30.17% | 25 | |||||||
59.21 | +40.58% | 14 | |||||||
82.83 | +8.00% | 6 | |||||||
69.82 | +41.92% | 16 | |||||||
127.35 | +47.14% | 17 | |||||||
48.43 | +54.03% | 14 | |||||||
Average | 13,161.98 | +29.97% | 16 | ||||||
Weighted average by Cap. | 23,846.24 | +23.02% | 18 |
- Stock Market
- Equities
- EVT Stock
- Sector Evotec SE
- Sector consensus
MarketScreener is also available in this country: United States.
Switch edition